Multiple Sclerosis Treatment: What Expert Care at the Right Time Can Do?

Multiple Sclerosis Treatment: What Expert Care at the Right Time Can Do?

Multiple sclerosis (MS) stands as a chronic condition where the immune system attacks the protective covering of nerves. Such a process disrupts communication between the brain and the rest of the body. While no cure exists currently, modern medical advancements provide numerous ways to manage multiple sclerosis symptoms and slow disease progression. Understanding the available paths allows patients to maintain hope and take control of their neurologic health with guidance from experienced neurologists at SRM Global Hospitals, Chennai.

Multiple Sclerosis (MS): Impact on the Central Nervous System

In multiple sclerosis (MS), the immune system mistakenly targets myelin, which acts as insulation for nerve fibres in the central nervous system, which contains the brain and spinal cord. Damage to this insulation (demyelination) leads to scarring or lesions that interfere with electrical signals travelling along the spinal cord and brain pathways, requiring timely evaluation by neurology specialists at SRM Global Hospitals.

Types of Multiple Sclerosis (MS)

Medical professionals classify multiple sclerosis (MS) based on how symptoms appear and progress (increase or change) over time. The main types include:

  • Relapsing-Remitting Multiple Sclerosis (RRMS): Patients experience clearly defined attacks, called relapses (sudden worsening of symptoms), where new symptoms appear, or old symptoms worsen. These are followed by recovery periods, called remission (phase of improvement), where symptoms partially or completely improve.
  • Clinically Isolated Syndrome (CIS): This refers to the first episode (single event) of neurological symptoms lasting at least 24 hours. It could or could not develop into multiple sclerosis. However, it can be an early warning sign assessed by neurologists at SRM Global Hospitals.
  • Primary Progressive Multiple Sclerosis (PPMS): In this type, symptoms gradually worsen from the beginning without clear relapses (sudden attacks) or recovery phases. The progression is steady (continuous worsening) in this type rather than episodic (happening in phases).
  • Secondary Progressive Multiple Sclerosis (SPMS): This usually develops after relapsing-remitting multiple sclerosis. Over time, the disease shifts from clear relapses to a more consistent and gradual decline in function, such as a slow reduction in the ability to move or perform daily activities.

Diagnosis of Multiple Sclerosis (MS)

Diagnosis of Multiple Sclerosis

Neurologists perform a comprehensive evaluation combining a physical examination with specialised tests. A detailed medical history serves as the starting point to track the onset of common symptoms through Mc Donald Criteria, followed by advanced neuroimaging and laboratory support services available at SRM Global Hospitals.

McDonald Criteria

The McDonald Criteria are internationally accepted guidelines used by neurologists to diagnose multiple sclerosis (MS). These criteria help confirm the disease by proving that damage has occurred in different parts of the central nervous system and at different points in time, such as:

  • Dissemination in Space (damage in different areas): This means lesions must be seen in more than one part of the central nervous system, such as the brain, spinal cord, or optic nerves.
  • Dissemination in time (damage at different times): This means there must be proof that new lesions have developed over time, showing that the disease is ongoing and not a single isolated event.
Since no single test confirms the disease, doctors use a combination of tools to meet these specific diagnostic criteria, such as:

Magnetic Resonance Imaging (MRI)

Magnetic resonance imaging remains a primary tool for diagnosing multiple sclerosis. These scans provide detailed pictures of the brain and spinal cord to look for lesions. It tracks active disease by highlighting new areas of inflammation and demyelination, interpreted by radiologists and neurologists at SRM Global Hospitals.

Lumbar Puncture and Spinal Fluid Analysis

A lumbar puncture, also known as a spinal tap, involves collecting spinal fluid from the lower back. Laboratory experts and neurologists check this spinal fluid for abnormalities such as elevated white blood cells or specific proteins. Such findings suggest an abnormal immune response within the nervous system.

Evoked Potential Tests

Evoked potential tests measure the electrical activity in the brain in response to specific stimuli such as light, sound, or touch. These tests help neurologists check how fast and efficiently nerve signals travel through the brain and spinal cord. In this test, delayed responses can indicate nerve damage related to multiple sclerosis, even if symptoms are mild or not clearly noticeable.

Differential Diagnosis

Differential diagnosis means ruling out other conditions that cause symptoms similar to multiple sclerosis. In this test, neurologists order blood tests to check for vitamin deficiencies, autoimmune conditions, or viral infections that can mimic multiple sclerosis symptoms.

Disease Modifying Therapies for Mutiple Sclerosis (MS)

Disease-modifying therapies (DMTs) represent the core of long-term management of Multiple Sclerosis. It aims to reduce relapses and limit the formation of new lesions. Starting early treatment with DMTs helps prevent permanent neurologic disability, as highly effective therapies used early in the course of the disease maximise control over disease progression under the supervision of neurologists at SRM Global Hospitals.

Injectable Medications

Interferon beta medications are long-standing options for relapsing forms. These drugs help regulate the immune system, but sometimes cause flu-like symptoms or injection site reactions. So, regular monitoring by neurologists and trained nursing teams helps manage these side effects effectively.

Oral Treatment Options

Several oral medications offer convenience for patients with relapsing-remitting MS to help reduce relapse rates and slow disease progression.

  • Fingolimod: The first oral DMT approved to reduce the frequency of MS attacks. It works by preventing certain immune cells from reaching the brain and spinal cord.
  • Dimethyl Fumarate: Activates the Nrf2 pathway (a protective mechanism in cells) to reduce inflammation and significantly lower relapse rates.
  • Teriflunomide: Inhibits pyrimidine synthesis (a process needed for immune cell multiplication), thereby reducing the number of white blood cells involved in the autoimmune attack.

For more active or aggressive cases, stronger oral options should be considered:

  • Siponimod and Ozanimod: These are selective S1P modulators (medicines that control immune cell movement). Ozanimod has shown lower relapse rates compared to interferon beta.
  • Cladribine: Approved for relapsing forms of MS, including active secondary progressive multiple sclerosis, and works by selectively reducing overactive immune cells.

Infusion Treatments

High-potency infusion treatments are usually recommended for patients with more active or aggressive multiple sclerosis to control the immune response, administered by experienced neurologists and infusion care teams at SRM Global Hospitals.

  • Ocrelizumab: Targets B cells (a type of white blood cell involved in nerve damage). It is approved to treat both relapsing-remitting multiple sclerosis and primary progressive multiple sclerosis. It is currently the only approved disease-modifying therapy shown to reduce the risk of disability progression in primary progressive MS.
  • Natalizumab: A monoclonal antibody (a lab-designed immune protein) that reduces relapse rates and slows disability progression in MS patients by preventing immune cells from entering the brain and spinal cord.
  • Alemtuzumab: Targets a specific protein on immune cells, reducing their activity. It has shown strong MRI improvements and significantly decreased annual relapse rates.

Managing an Acute Multiple Sclerosis (MS) Attack

An MS attack or relapse involves new or worsening symptoms that last more than 24 hours.

  • To relieve symptoms quickly, doctors prescribe high-dose corticosteroids. These medications reduce inflammation at the site of the immune system attacks.
  • In cases where steroids fail, a protein solution called albumin can be used during plasma exchange. This process cleanses the blood of harmful antibodies to speed up recovery from severe relapses under close monitoring by neurologists and critical care specialists.

Symptom Management in Multiple Sclerosis (MS)

Symptom Management in Multiple Sclerosis (MS)

While disease-modifying therapies (DMTs) focus on slowing future disease activity, symptom management focuses on improving daily quality of life.

Fatigue Management

Fatigue affects nearly 76% to 92 % of people with MS and is one of the most common and disabling symptoms. It can occur even without heavy physical activity. Neurologists prescribe amantadine as a first-line medication, along with lifestyle strategies such as planned rest, energy conservation, and structured exercise.

Pain Relief

Pain affects about 30% to 50% of patients, which include nerve pain, burning sensations, or musculoskeletal discomfort. Neurologists and pain management specialists commonly use tricyclic antidepressants as first-line treatment for nerve-related pain, as they help calm irritated nerve pathways.

Muscle Spasms and Stiffness

Muscle stiffness and spasms, also called spasticity, can interfere with movement and sleep. Muscle relaxants prescribed by neurologists, along with regular stretching and physiotherapy guided by rehabilitation specialists, help reduce tightness and improve flexibility.

Walking and Mobility

MS can weaken leg muscles and affect balance. Sustained-release dalfampridine improves walking speed in some patients. Physical therapy strengthens muscles and improves coordination, while mobility aids such as canes or walkers support safer movement when needed.

Bladder and Bowel Function

Bladder problems involve difficulty storing urine (frequent urgency) or difficulty emptying the bladder. Constipation is the most common bowel issue in MS. Urologists and rehabilitation specialists guide treatment, which includes pelvic floor exercises, dietary adjustments, and medications.

Sexual Health

Sexual dysfunction results from nerve damage or from related symptoms such as fatigue, depression, or anxiety. Open discussion with neurologists or mental health specialists helps identify medical and psychological solutions.

Heat Intolerance

Many patients experience worsening of symptoms in hot weather. So, avoiding saunas, hot tubs, and prolonged hot showers and using cooling techniques can help prevent temporary symptom flare-ups.

Physical Therapy in Multiple Sclerosis (MS)

Physical Therapy in Multiple Sclerosis

Physical therapy provides structured and supervised training to maintain mobility and independence in people with multiple sclerosis. A physiotherapist or occupational therapist creates an individual plan based on strength, balance, and daily function needs, with exercises such as:

  • Stretching Exercises: Help reduce muscle stiffness and improve flexibility, especially in patients with spasticity.
  • Strengthening Exercises: Build muscle power, support weak limbs, and improve coordination.
  • Balance Training: Enhances stability and reduces the risk of falls.
  • Low-Impact Activities: Activities such as walking, swimming, cycling, and yoga improve stamina without overstraining the body.

Regular, moderate exercise is more beneficial than sudden, intense workouts. It should be performed under professional guidance for best results, such as:

  • Fatigue Management: Regular moderate exercise improves energy levels over time and reduces MS-related fatigue.
  • Brain and Spinal Cord Support: Consistent physical activity has protective effects on neurological health and supports long-term function.

Lifestyle Choices in Multiple Sclerosis (MS)

Maintaining a healthy lifestyle plays an important role in managing multiple sclerosis and improving overall quality of life, such as:

  • Mediterranean Diet: This eating pattern is rich in fish, leafy vegetables, fruits, whole grains, olive oil, and nuts, while being low in red meat and processed foods. It supports heart health and has shown neuroprotective (brain-protecting) benefits in people with MS.
  • Vitamin D: Adequate vitamin D levels are important in MS management. Many neurologists recommend a daily intake of 2,000 to 5,000 international units of vitamin D3, depending on blood levels and medical advice.
  • Healthy Weight: Being overweight is associated with a higher risk of developing MS and contributes to more active disease. Maintaining a balanced weight reduces strain on mobility and supports overall health.
  • Smoking Cessation: Smoking is linked to faster disease progression and increased disability in MS patients. Quitting smoking is one of the most important lifestyle changes for long-term disease control.

Healthy lifestyle habits, when combined with medical treatment and multidisciplinary care from neurologists, rehabilitation specialists, and clinical nutrition experts, significantly influence long-term outcomes and daily functioning in people living with MS.

Book an Appointment for Advanced Care Focused on Long-Term Stability

SRM Global Hospitals in Chennai offers comprehensive multiple sclerosis management designed around clear diagnosis, disease control, and functional independence.

  • Neurological evaluation conducted by experienced neurologists trained in managing complex demyelinating disorders.
  • Advanced MRI imaging and neurodiagnostic services to detect lesions early and monitor disease activity accurately.
  • Evidence-based disease-modifying therapy planning for relapsing and progressive forms of MS.
  • Dedicated infusion therapy services with monitored administration of high-efficacy treatments.
  • Multidisciplinary symptom management mainly involves neurologists, pain specialists, rehabilitation physicians, and physiotherapists.
  • Structured physical therapy and mobility programs focused on balance, strength, and fall prevention.
  • Long-term follow-up protocols to adjust treatment plans based on disease progression and patient response.
  • Integrated lifestyle and nutrition guidance to support immune health and overall neurological well-being.

FAQs on Multiple Sclerosis Treatment

1. If I Have Clinically Isolated Syndrome, Does That Mean I Have Multiple Sclerosis?

Clinically isolated syndrome is a first episode of neurological symptoms that could or could not develop into a relapsing disease. So, in this case, neurologists monitor MRI findings and risk factors closely because early diagnosis and timely treatment to reduce future MS relapses and long-term disability.

2. How is Multiple Sclerosis Treated in Relapsing and Secondary Progressive Stages?

Relapsing forms are commonly treated with disease-modifying therapies with medications such as interferon beta, cladribine, ozanimod, and other B-cell therapy options. Currently, treatment choices are limited for non-active secondary progressive MS, but active secondary progressive MS still benefit from approved therapies used in relapsing disease.

3. How Are Primary Progressive Forms of Ms Treated?

Primary progressive forms have fewer approved treatment options, such as ocrelizumab, which works by targeting B cells involved in immune damage.

4. Why Do Doctors Check White Blood Cell Count During Ms Treatment?

Some disease-modifying therapies can affect the immune system and lower white blood cell count, so neurologists check this count through blood tests to ensure the treatment is safe and adjust doses if needed.